Collegium Pharmaceutical
COLL
eBay
EBAY
Halozyme Therapeutics
HALO
SilverCrest Metals
SILV
Workday
WDAY
US Stock MarketDetailed Quotes
SAGE Sage Therapeutics
- 5.850
- -0.130-2.17%
Close Jan 8 16:00 ET
- 5.850
- 0.0000.00%
Post 20:01 ET
357.86MMarket Cap-1.05P/E (TTM)
6.055High5.720Low723.00KVolume5.940Open5.980Pre Close4.29MTurnover1.50%Turnover RatioLossP/E (Static)61.17MShares27.67552wk High0.65P/B282.74MFloat Cap4.62052wk Low--Dividend TTM48.33MShs Float195.970Historical High--Div YieldTTM5.60%Amplitude4.620Historical Low5.931Avg Price1Lot Size
About Sage Therapeutics Company
SAGE Therapeutics, Inc. is a biopharmaceutical company, which engages in providing solutions to brain health medicines. It focuses on diseases and disorders of the brain. Its products include ZURZUVAE and ZULRESSO. The company was founded by Steven Marc Paul and Douglas Covey on April 16, 2010 and is headquartered in Cambridge, MA.
Company Profile
SymbolSAGE
Company NameSage Therapeutics
Listing DateJul 18, 2014
Issue Price18.00
Founded2010
CEOMr. Barry E. Greene
MarketNASDAQ
Employees487
Fiscal Year Ends12-31
Address55 Cambridge Parkway
CityCambridge
ProvinceMassachusetts
CountryUnited States of America
Zip Code02142
Phone1-617-299-8380
Websitehttp://www.sagerx.com
Company Executives
- Name
- Position
- Salary
- Barry E. Greene
- Director, President and Chief Executive Officer
- 6.24M
- Christopher Benecchi
- Chief Operating Officer, Treasurer, Principal Financial and Accounting Officer
- 2.28M
- Laura Gault, M.D.,PhD
- Chief Medical Officer
- 1.27M
- Michael F. Cola
- Independent Director
- 440.05K
- Dr. Steven M. Paul, M.D.
- Independent Director
- 420.05K
- Dr. George S. Golumbeski, PhD
- Independent Director
- 412.55K
- Jessica J. Federer
- Independent Director
- 962.23K
- Elizabeth Barrett
- Independent Director
- 425.05K
- James M. Frates
- Independent Director
- 435.05K
- Geno J. Germano
- Independent Director
- 417.55K